EI
DNA icon

Ellevest Inc’s Ginkgo Bioworks DNA Stock Holding History

Ellevest Inc’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-427
Closed -$28.9K – 409
2023
Q4 		$28.9K Sell
427
-268
-39% -$16.4K ﹤0.01% 384
2023
Q3 		$50.3K Buy
695
+55
+9% +$4.4K ﹤0.01% 345
2023
Q2 		$47.6K Buy
640
+471
+279% +$27.9K ﹤0.01% 355
2023
Q1 		$8.97K Sell
169
-87
-34% -$5.51K ﹤0.01% 1054
2022
Q4 		$17.3K Buy
256
+108
+73% +$9.93K ﹤0.01% 892
2022
Q3 		$18K Buy
+148
New +$17.6K ﹤0.01% 835

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ellevest Inc's DNA Position: Q1 2024 in Review

Ellevest Inc sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 427 shares — an estimated $28.9K sold.

Ellevest Inc first reported a position in DNA in Q3 2022 and held it in 6 quarters. The position peaked at $50.3K in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Ellevest Inc reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Ellevest Inc sold 427 Ginkgo Bioworks shares in Q1 2024, an estimated $28.9K.
  • Ellevest Inc first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 6 quarters.
  • Ellevest Inc's Ginkgo Bioworks position peaked at $50.3K in Q3 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Ellevest Inc's 13F filing for Q1 2024, filed 13 May 2024.